{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:16:59Z","timestamp":1787818619642,"version":"build-2784847793"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Revitalisation Talents Program of LiaoNing Province","award":["XLY1807083"],"award-info":[{"award-number":["XLY1807083"]}]},{"name":"the Science and Technology Innovation for Public Welfare Project of Dalian","award":["2024JJ13PT051"],"award-info":[{"award-number":["2024JJ13PT051"]}]},{"name":"Dalian Medical Key Specialties \"Summit Project\"","award":["2024ZZ041"],"award-info":[{"award-number":["2024ZZ041"]}]},{"name":"the Key Research and Development Program of Liaoning Province","award":["2025ZXYYCR003"],"award-info":[{"award-number":["2025ZXYYCR003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12975-026-01470-5","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:11:02Z","timestamp":1785474662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Antioxidant DI-3-N-Butylphthalide on Hemorrhagic Transformation Assessed by Propensity Score Matching in a Real-World Thrombolyzed Ischemic Stroke Patient Setting"],"prefix":"10.1007","volume":"17","author":[{"given":"Ziqi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tieping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Minor","family":"Murakami Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-3713","authenticated-orcid":false,"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"10","key":"1470_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"VL Feigin","year":"2021","unstructured":"Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820. https:\/\/doi.org\/10.1016\/S1474-4422(21)00252-0.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1470_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ncl.2021.02.001","volume":"39","author":"AS Zubair","year":"2021","unstructured":"Zubair AS, Sheth KN. Emergency Care of Patients with Acute Ischemic Stroke. Neurol Clin. 2021;39(2):391\u2013404. https:\/\/doi.org\/10.1016\/j.ncl.2021.02.001.","journal-title":"Neurol Clin"},{"issue":"6","key":"1470_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jstrokecerebrovasdis.2004.03.003","volume":"13","author":"RI Lindley","year":"2004","unstructured":"Lindley RI, Wardlaw JM, Sandercock PAG, et al. Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction. J Stroke Cerebrovasc Dis. 2004;13(6):235\u201346. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2004.03.003.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9958","key":"1470_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","volume":"384","author":"J Emberson","year":"2014","unstructured":"Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(14)60584-5.","journal-title":"Lancet"},{"issue":"11","key":"1470_CR5","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/ene.15482","volume":"29","author":"J He","year":"2022","unstructured":"He J, Fu F, Zhang W, Zhan Z, Cheng Z. Prognostic significance of the clinical and radiological haemorrhagic transformation subtypes in acute ischaemic stroke: A systematic review and meta-analysis. Euro J Neurol. 2022;29(11):3449\u201359. https:\/\/doi.org\/10.1111\/ene.15482.","journal-title":"Euro J Neurol"},{"issue":"2","key":"1470_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/2040622310394032","volume":"2","author":"Z Zaheer","year":"2011","unstructured":"Zaheer Z, Robinson T, Mistri AK. Thrombolysis in acute ischaemic stroke: an update. Therapeutic Adv Chronic Disease. 2011;2(2):119\u201331. https:\/\/doi.org\/10.1177\/2040622310394032.","journal-title":"Therapeutic Adv Chronic Disease"},{"key":"1470_CR7","unstructured":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association. PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/29097489\/ Accessed 30 Mar 2025."},{"key":"1470_CR8","doi-asserted-by":"publisher","unstructured":"Y Z, S Y, X S, et al. Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers. BMC Neurol. 2019;19(1). https:\/\/doi.org\/10.1186\/s12883-019-1418-z.","DOI":"10.1186\/s12883-019-1418-z"},{"issue":"11","key":"1470_CR9","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1161\/hs1101.097381","volume":"32","author":"E Kilic","year":"2001","unstructured":"Kilic E, Bahr M, Hermann DM. Effects of Recombinant Tissue Plasminogen Activator After Intraluminal Thread Occlusion in Mice: Role of Hemodynamic Alterations. Stroke. 2001;32(11):2641\u20137. https:\/\/doi.org\/10.1161\/hs1101.097381.","journal-title":"Stroke"},{"issue":"2","key":"1470_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1600-079X.2005.00228.x","volume":"39","author":"E Kilic","year":"2005","unstructured":"Kilic E, Kilic \u00dc, Reiter RJ, Bassetti CL, Hermann DM. Tissue-plasminogen activator\u2010induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt. J Pineal Res. 2005;39(2):151\u20135. https:\/\/doi.org\/10.1111\/j.1600-079X.2005.00228.x.","journal-title":"J Pineal Res"},{"issue":"12","key":"1470_CR11","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/s41401-023-01137-z","volume":"44","author":"DM Dai","year":"2023","unstructured":"Dai M, Gui XX, Jia SM, Lv ST, Dou H, Cui W. Dl-3-n-butylphthalide promotes angiogenesis in ischemic stroke mice through upregulating autocrine and paracrine sonic hedgehog. Acta Pharmacol Sin. 2023;44(12):2404\u20132417. https:\/\/doi.org\/10.1038\/s41401-023-01137-z","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"1470_CR12","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/00005344-200406000-00018","volume":"43","author":"Y Peng","year":"2004","unstructured":"Peng Y, Zeng X, Feng Y, Wang X. Antiplatelet and Antithrombotic Activity of L-3-n-butylphthalide in Rats. J Cardiovasc Pharmacol. 2004;43(6):876\u201381. https:\/\/doi.org\/10.1097\/00005344-200406000-00018.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"12","key":"1470_CR13","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1002\/acn3.52238","volume":"11","author":"J Tian","year":"2024","unstructured":"Tian J, Yang P, Yang J, et al. Efficacy and safety of DL-3\u2010N\u2010butylphthalide in the treatment of ischemic poststroke aphasia: A randomized clinical trial. Ann Clin Transl Neurol. 2024;11(12):3300\u20139. https:\/\/doi.org\/10.1002\/acn3.52238.","journal-title":"Ann Clin Transl Neurol"},{"issue":"12","key":"1470_CR47","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.62347\/eipn6922","volume":"16","author":"A Liu","year":"2024","unstructured":"Liu A. Efficacy of butylphthalein injection combined with alteplasethrombolysis in patients with acute cerebral infarction and its impact on Lp-PLA2 and CXCL16 levels. Am J Transl Res. 2024;16(12):8054\u201362. . https:\/\/doi.org\/10.62347\/eipn6922","journal-title":"Am J Transl Res"},{"issue":"2","key":"1470_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3760\/cma.j.issn.0366-6999.20121113","volume":"126","author":"H Sun","year":"2013","unstructured":"Sun H, Zhang J, Wang J, Sun T, Xiao H, Zhang JS. Association between genetic variants of the leukotriene biosynthesis pathway and the risk of stroke: a case-control study in the Chinese Han population. Chin Med J (Engl). 2013;126(2):254\u20139.","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"1470_CR15","first-page":"505","volume":"18","author":"ZZ Chong","year":"1997","unstructured":"Chong ZZ, Feng YP. Effects of dl-3-n-butylphthalide on production of TXB2 and 6-keto-PGF1 alpha in rat brain during focal cerebral ischemia and reperfusion. Zhongguo Yao Li Xue Bao. 1997;18(6):505\u20138.","journal-title":"Zhongguo Yao Li Xue Bao"},{"issue":"5","key":"1470_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.21037\/qims.2017.10.08","volume":"7","author":"Y Wang","year":"2017","unstructured":"Wang Y, Qi W, Zhang L, et al. The novel targets of DL-3-n-butylphthalide predicted by similarity ensemble approach in combination with molecular docking study. Quant Imaging Med Surg. 2017;7(5):532\u20136. https:\/\/doi.org\/10.21037\/qims.2017.10.08.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"1470_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40779-021-00314-7","volume":"8","author":"G Xu","year":"2021","unstructured":"Xu G, Shi YK, Sun BD, et al. DL-3-n-butylphthalide improved physical and learning and memory performance of rodents exposed to acute and chronic hypobaric hypoxia. Military Med Res. 2021;8(1):23. https:\/\/doi.org\/10.1186\/s40779-021-00314-7.","journal-title":"Military Med Res"},{"issue":"3","key":"1470_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41401-020-00583-3","volume":"42","author":"Bni Wang","year":"2021","unstructured":"Wang Bni, Wu Cbiao, Chen Z, miao, et al. DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K\/Akt signaling and suppressing oxidative stress. Acta Pharmacol Sin. 2021;42(3):347\u201360. https:\/\/doi.org\/10.1038\/s41401-020-00583-3.","journal-title":"Acta Pharmacol Sin"},{"key":"1470_CR19","doi-asserted-by":"publisher","first-page":"103835","DOI":"10.1016\/j.redox.2025.103835","volume":"86","author":"G Li","year":"2025","unstructured":"Li G, Xiao H, Zuo C, et al. N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity. Redox Biol. 2025;86:103835. https:\/\/doi.org\/10.1016\/j.redox.2025.103835.","journal-title":"Redox Biol"},{"issue":"5","key":"1470_CR20","doi-asserted-by":"publisher","first-page":"e00444","DOI":"10.1016\/j.neurot.2024.e00444","volume":"21","author":"M Sun","year":"2024","unstructured":"Sun M, Chen J, Liu F, et al. Butylphthalide inhibits ferroptosis and ameliorates cerebral Ischaemia\u2013Reperfusion injury in rats by activating the Nrf2\/HO-1 signalling pathway. Neurotherapeutics. 2024;21(5):e00444. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00444.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1470_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3760\/cma.j.issn.1006-7876.2019.04.003","volume":"52","author":"Chinese Medical Association Neurology Branch, Chinese Medical Association Neurology Branch Cerebrovascular Disease Group","year":"2019","unstructured":"Chinese Medical Association Neurology Branch, Chinese Medical Association Neurology Branch Cerebrovascular Disease Group. China Acute Cerebral Infarction Hemorrhagic Transformation Diagnosis and Treatment Consensus. Chin J Neurol. 2019;52(4):252\u201365. https:\/\/doi.org\/10.3760\/cma.j.issn.1006-7876.2019.04.003.","journal-title":"Chin J Neurol"},{"issue":"9136","key":"1470_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","volume":"352","author":"W Hacke","year":"1998","unstructured":"Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998;352(9136):1245\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(98)08020-9.","journal-title":"Lancet"},{"key":"1470_CR23","unstructured":"China Pharmacoeconomic Evaluation Guidelines. 2020: T\/CPHARMA 003-2020[S]. 2020."},{"issue":"8","key":"1470_CR24","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaneurol.2023.1871","volume":"80","author":"A Wang","year":"2023","unstructured":"Wang A, Jia B, Zhang X, et al. Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2023;80(8):851. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1871.","journal-title":"JAMA Neurol"},{"issue":"10","key":"1470_CR25","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1177\/0271678X231168507","volume":"43","author":"ZN Guo","year":"2023","unstructured":"Guo ZN, Yue BH, Fan L, et al. Effectiveness of butylphthalide on cerebral autoregulation in ischemic stroke patients with large artery atherosclerosis (EBCAS study): A randomized, controlled, multicenter trial. J Cereb Blood Flow Metab. 2023;43(10):1702\u201312. https:\/\/doi.org\/10.1177\/0271678X231168507.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1470_CR48","doi-asserted-by":"publisher","unstructured":"Wang H, Ye K, Li D, Liu Y, Wang D. DL-3-n-butylphthalide for acuteischemic stroke: an updated systematic review and meta-analysis ofrandomized controlled trials. Front Pharmacol. 2022;13:963118. https:\/\/doi.org\/10.3389\/fphar.2022.963118","DOI":"10.3389\/fphar.2022.963118"},{"issue":"8","key":"1470_CR26","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1161\/STROKEAHA.107.505420","volume":"39","author":"A Kastrup","year":"2008","unstructured":"Kastrup A, Gr\u00f6schel K, Ringer TM, et al. Early Disruption of the Blood\u2013Brain Barrier After Thrombolytic Therapy Predicts Hemorrhage in Patients With Acute Stroke. Stroke. 2008;39(8):2385\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.107.505420.","journal-title":"Stroke"},{"issue":"4","key":"1470_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-021-00605-6","volume":"18","author":"M Fisher","year":"2022","unstructured":"Fisher M, Savitz SI. Pharmacological brain cytoprotection in acute ischaemic stroke \u2014 renewed hope in the reperfusion era. Nat Rev Neurol. 2022;18(4):193\u2013202. https:\/\/doi.org\/10.1038\/s41582-021-00605-6.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1470_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1179\/1743132814Y.0000000412","volume":"37","author":"P Golab","year":"2015","unstructured":"Golab P, Kielbus M, Bielewicz J, Kurzepa J. The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activities in vitro. Neurol Res. 2015;37(1):9\u201313. https:\/\/doi.org\/10.1179\/1743132814Y.0000000412.","journal-title":"Neurol Res"},{"issue":"8","key":"1470_CR29","first-page":"796","volume":"24","author":"C Qing","year":"2003","unstructured":"Qing C, Xiao-Liang W. Effects of chiral 3-n-butylphthalide on apoptosis induced by transient focal cerebral ischemia in rats. Acta Pharmacol Sin. 2003;24(8):796\u2013804.","journal-title":"Acta Pharmacol Sin"},{"issue":"1\u20132","key":"1470_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2007.04.025","volume":"260","author":"CL Liu","year":"2007","unstructured":"Liu CL, Liao SJ, Zeng JS, et al. dl-3n-butylphthalide prevents stroke via improvement of cerebral microvessels in RHRSP. J Neurol Sci. 2007;260(1\u20132):106\u201313. https:\/\/doi.org\/10.1016\/j.jns.2007.04.025.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1470_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.018","volume":"25","author":"H Zhao","year":"2016","unstructured":"Zhao H, Yun W, Zhang Q, et al. Mobilization of Circulating Endothelial Progenitor Cells by dl-3-n-Butylphthalide in Acute Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2016;25(4):752\u201360. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2015.11.018.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"1470_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/09537104.2014.989826","volume":"26","author":"J Ye","year":"2015","unstructured":"Ye J, Zhai L, Zhang S, et al. dl -3- n -butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA 2 synthesis and phosphodiesterase. Platelets. 2015;26(8):736\u201344. https:\/\/doi.org\/10.3109\/09537104.2014.989826.","journal-title":"Platelets"},{"issue":"8","key":"1470_CR33","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jamaneurol.2023.1871","volume":"80","author":"A Wang","year":"2023","unstructured":"Wang A, Jia B, Zhang X, et al. Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial. JAMA Neurol. 2023;80(8):851. https:\/\/doi.org\/10.1001\/jamaneurol.2023.1871.","journal-title":"JAMA Neurol"},{"key":"1470_CR34","first-page":"507","volume":"1905","author":"A Feng","year":"2017","unstructured":"Feng A, et al. Analysis of Risk Factors for Hemorrhagic Transformation and Its Subtypes Following Cerebral Infarction. J Chin Geriatric Cardiovasc Cerebrovasc Dis. 2017;1905:507\u201312.","journal-title":"J Chin Geriatric Cardiovasc Cerebrovasc Dis"},{"issue":"8","key":"1470_CR35","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3109\/10428194.2015.1110747","volume":"57","author":"BY Lu","year":"2016","unstructured":"Lu BY, Thanawala SU, Zochowski KC, Burke MJ, Carroll WL, Bhatla T. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples. Leuk Lymphoma. 2016;57(8):1938\u201341. https:\/\/doi.org\/10.3109\/10428194.2015.1110747.","journal-title":"Leuk Lymphoma"},{"issue":"23","key":"1470_CR36","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.3390\/jcm11237148","volume":"11","author":"C Ming","year":"2022","unstructured":"Ming C, Toh EMS, Yap QV, et al. Impact of Traditional and Non-Traditional Lipid Parameters on Outcomes after Intravenous Thrombolysis in Acute Ischemic Stroke. JCM. 2022;11(23):7148. https:\/\/doi.org\/10.3390\/jcm11237148.","journal-title":"JCM"},{"issue":"5","key":"1470_CR37","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/STROKEAHA.111.671966","volume":"44","author":"SR Mess\u00e9","year":"2013","unstructured":"Mess\u00e9 SR, Pervez MA, Smith EE, et al. Lipid Profile, Lipid-lowering Medications, and Intracerebral Hemorrhage After tPA in Get With The Guidelines\u2013Stroke. Stroke. 2013;44(5):1354\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.111.671966.","journal-title":"Stroke"},{"issue":"02","key":"1470_CR38","first-page":"130","volume":"21","author":"Wang","year":"2024","unstructured":"Wang, Xin, et al. Research Progress on the Correlation between High-density Lipoprotein Cholesterol and Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke. China J Cerebrovasc Dis. 2024;21(02):130\u20137.","journal-title":"China J Cerebrovasc Dis"},{"issue":"5","key":"1470_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/bloodadvances.2023011744","volume":"8","author":"F Lebrun","year":"2024","unstructured":"Lebrun F, Levard D, Lemarchand E, et al. Improving stroke outcomes in hyperglycemic mice by modulating tPA\/NMDAR signaling to reduce inflammation and hemorrhages. Blood Adv. 2024;8(5):1330\u201344. https:\/\/doi.org\/10.1182\/bloodadvances.2023011744.","journal-title":"Blood Adv"},{"issue":"6","key":"1470_CR40","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.STR.14.6.893","volume":"14","author":"AM Hakim","year":"1983","unstructured":"Hakim AM, Ryder-Cooke A, Melanson D. Sequential computerized tomographic appearance of strokes. Stroke. 1983;14(6):893\u20137. https:\/\/doi.org\/10.1161\/01.STR.14.6.893.","journal-title":"Stroke"},{"key":"1470_CR41","doi-asserted-by":"publisher","unstructured":"Hj L, Pa W, M KH, et al. Stroke severity in atrial fibrillation. Framingham Study Stroke. 1996;27(10). https:\/\/doi.org\/10.1161\/01.str.27.10.1760.","DOI":"10.1161\/01.str.27.10.1760"},{"issue":"8","key":"1470_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4070\/kcj.2011.41.8.490","volume":"41","author":"JS Kim","year":"2011","unstructured":"Kim JS, Yang WI, Shim CY, Ha JW, Chung N, Chang HJ. Hemorrhagic Transformation of Ischemic Stroke: Severe Complications of Prosthetic Valve Endocarditis. Korean Circ J. 2011;41(8):490. https:\/\/doi.org\/10.4070\/kcj.2011.41.8.490.","journal-title":"Korean Circ J"},{"issue":"5","key":"1470_CR45","first-page":"541","volume":"50","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Hu J, ping, Jiang J, Li Y, Hu P. Interaction of butylphthalide with rat and human liver CYP450 isoenzymes. Yao Xue Xue Bao. 2015;50(5):541\u20136.","journal-title":"Yao Xue Xue Bao"},{"issue":"2","key":"1470_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/dmd.112.049684","volume":"41","author":"X Diao","year":"2013","unstructured":"Diao X, Deng P, Xie C, et al. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation. Drug Metab Dispos. 2013;41(2):430\u201344. https:\/\/doi.org\/10.1124\/dmd.112.049684.","journal-title":"Drug Metab Dispos"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01470-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-026-01470-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-026-01470-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T07:18:18Z","timestamp":1787815098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-026-01470-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1470"],"URL":"https:\/\/doi.org\/10.1007\/s12975-026-01470-5","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"value":"1868-4483","type":"print"},{"value":"1868-601X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Central Hospital of Dalian University of Technology approved this study (registration number: YN2022-069-01). Patients signed informed consent that the data of this cohort can be used in scientific analyses and papers. The study adhered to the Declaration of Helsinki and its amendments.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"91"}}